New research has shown that medical cannabis may effectively manage fibromyalgia and associated symptoms of depression and anxiety.

MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) said the study was conducted by its subsidiary Harvest Medicine.

Titled "Self-Reported Effects of Illness Severity, Depression and Anxiety in Fibromyalgia Patients: A Large Retrospective Case Series," the study was published in the peer-reviewed American Journal of Endocannabinoid Medicine.

The Study And Key Findings

Full story available on

A note to our visitors

This website has updated its privacy policy in compliance with changes to European Union data protection law, for all members globally. We’ve also updated our Privacy Policy to give you more information about your rights and responsibilities with respect to your privacy and personal information. Please read this to review the updates about which cookies we use and what information we collect on our site. By continuing to use this site, you are agreeing to our updated privacy policy.